A compound selected from (2S)-2-Ä(4S)-4-(2,2-difluorovinyl)-2-oxopyrrolidinylÜbutanamide or a pharmaceutically acceptable salt thereof. <;??>;The compounds of the invention are particularly suited for treating neurological disorders such as epilepsy.